Notification on alienation of significant holding

JSC “Grindeks” hereby informs that on 2 November 2010 it has received a
notification from JSC “Pharmstandard” on the alienation of the ownership of
11.38% shares of the JSC “Grindeks”. 

In the attachment: Notification from JSC “Pharmstandard” on four pages.


Further information:
Laila Kļaviņa 
Head of the Communications Department JSC “Grindeks” 
Phones: (+371) 67083370, (+371) 29256012
Fax: (+371) 67083505
E-mail: laila.klavina@grindeks.lv